SCLERODERMA & RAYNAUD'S UK
Registered charity 1161828 · accounts filings on the Charity Commission register · also known as SCLERODERMA & RAYNAUD?S UK, SRUK
To promote and support research into the causes, treatment, care and prevention of scleroderma and Raynaud's and related disorders and to disseminate the results of such research; and to advance Education and Awareness of scleroderma and Raynaud's and related disorders, including but not limited to the provision and production of educational literature.
Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net deficit of £1,044,724 for the year ended 31 March 2025, driven by increased expenditure on research and services. Despite this deficit, the trustees confirm that unrestricted reserves of £3,594,375 are in excess of the stated policy target of approximately £1 million, and there are no material uncertainties regarding the charity's ability to continue as a going concern.
Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.
What the accounts disclose
Trading subsidiary: RSA Trading Company Limited
“The subsidiary was registered in England and Wales with registered number 07869668. A decision has been taken to sell the remaining stock and cease trading.” — page 39
Per its FY2025 accounts as filed with the Charity Commission.
Accounts audited by Azets Audit Services. Discloses 3 of 6 completeness components.
Corporate structure
RSA TRADING COMPANY LIMITED — per its own Companies House accounts
Public fundraising profile: JustGiving — Scleroderma & Raynaud's UK (SRUK) (matched by registered charity number).
Structured financials (annual return, FY ending 31/03/2024)
Cost of raising funds
£289k
Reported reserves equal ~22.7 months of spending — in the top quarter for charities its size (median 7.0 months; benchmarks).
Per its annual return, cost of raising funds: 29.0% of total income — above the 90th percentile for charities its size (median 2.9%) (benchmarks).
- Chris Skeet
- Elliot Grey Dunster
- Jason Anthony Bryant
- Kellie Scott
- Professor Allan Lawrie
- Professor Dorian Haskard
Trustee list from the Charity Commission register (current, not historical).
Operates in: Northern Ireland · Scotland · Throughout England And Wales
Income and spending
Common questions
Is SCLERODERMA & RAYNAUD'S UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net deficit of £1,044,724 for the year ended 31 March 2025, driven by increased expenditure on research and services. Despite this deficit, the trustees confirm that unrestricted reserves of £3,594,375 are in excess of the stated policy target of approximately £1 million, and there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were audited by Azets Audit Services.
Who funds SCLERODERMA & RAYNAUD'S UK?
Funders whose own accounts filings name SCLERODERMA & RAYNAUD'S UK as a grant recipient include TOM AND SHEILA SPRINGER CHARITY, THE ADINT CHARITABLE TRUST, THE CHARLES LITTLEWOOD HILL TRUST, THE ARDWICK TRUST.
Known funders
Grants to this charity found in funders’ own accounts filings.
Government & lottery funding
Grants to this charity published as open data by government and lottery funders (360Giving).
Funders of similar charities
Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.
Charities like this
Semantically similar by activities and financial character, from our analysed corpus. Compare with BRITISH SJOGRENS SYNDROME ASSOCIATION.
Side by side with its peers
Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.